JonathanLCurryMD

Dermatopathology, Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Curry?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Jonathan Curry, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas and Illinois. He is affiliated with University of Texas M.D. Anderson Cancer Center.

Loyola University Medical CenterResidency, Pathology-Anatomic and Clinical, 1998 - 2003
Loyola University Chicago Stritch School of MedicineClass of 1998

PubMed

BCR::ZNF711 and BCR::CYLC2 Fusions: Novel BCR Fusions Expanding the Molecular Spectrum of Gene Fusions in Melanoma.
Elsayed Ibrahim, Richard K Yang, Jonathan L Curry, Woo Cheal Cho
The American Journal of Dermatopathology. 2024-11-01
Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous Melanoma.
Debora A Ledesma, Mario L Marques-Piubelli, Elsa Li-Ning-Tapia, Courtney Hudgens, Jun Gu
The American Journal of Dermatopathology. 2024-07-01
1 citations
Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review.
Haneen T Salah, Richard K Yang, Sinchita Roy-Chowdhuri, Merrick I Ross, Phyu P Aung
Journal of Cutaneous Pathology. 2024-06-01

Is Immunohistochemical Expression of GATA3 Helpful in the Differential Diagnosis of Transformed Mycosis Fungoides and Primary Cutaneous CD30-Positive T Cell Lymphoproliferative Disorders?February 18th, 2021
Cover ImageAugust 16th, 2019